) has announced the publication of the findings from the INSTRIDE
WalkAide trial conducted by the company. The findings of the
trial have been published in the peer-reviewed journal called
Neurorehabilitation and Neural Repair, under the title 'The
Effects of Peroneal Nerve Functional Electrical Stimulation
versus Ankle-Foot Orthosis in Patients with Chronic Stroke: a
Randomized Controlled Trial'.
The INSTRIDE multi-center randomized controlled trial was
undertaken by Hanger to compare changes in gait and quality of
life between individuals used to wearing the WalkAide and those
using an Ankle Foot Orthosis (AFO).
The INSTRIDE WalkAide trial of Hanger covered 495 participants
all of whom were identified as chronic stroke patients and had
suffered a stroke in the past six months. Additionally, the
participants also suffered from a form of lower leg paralysis or
weakness known as foot drop.
Foot drop, which is also known as drop foot, refers to a
patient's inability to lift his or her foot naturally. Such
impairment can naturally hinder a patient's normal activities in
his daily life.
The clinical trial confirmed that WalkAide is equivalent to the
current standard of care- the Ankle Foot Orthosis (AFO)
conventional brace, in bringing about improvements in gait speed
and stroke-related quality of life measures. The trial results
further validated that with the usage of the WalkAide,
statistically significant and clinically-relevant improvements
were noticed in a patient's mobility.
The results of the INSTRIDE WalkAide trial by Hanger validate
this medical device as a suitable alternative to conventional
bracing, particularly in people suffering from foot drop caused
by chronic stroke.
The results from the trial by Hanger have been presented to the
Centers of Medicare and Medicaid Services (CMS), an agency within
the U.S. Department of Health & Human Services. CMS will take
into consideration the findings of the trial enabling the highly
advanced medical device to reach out to larger number of patients
currently suffering from foot drop.
Currently, Hanger carries a Zacks Rank #5 (Strong Sell).
Investors interested in the medical products industry can look at
other stocks like
Baxter International Inc
). While NUVA carries a Zacks Rank #1 (Strong Buy), COV and BAX
hold a Zacks Rank #2 (Buy).
BAXTER INTL (BAX): Free Stock Analysis Report
COVIDIEN PLC (COV): Free Stock Analysis
HANGER ORTHOPED (HGR): Free Stock Analysis
NUVASIVE INC (NUVA): Free Stock Analysis
To read this article on Zacks.com click here.